Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

PT-141 Research Concentration Comparison

0.5mg/mL Receptor binding assays, low-density cell cultures 21–28 days Low (adsorption to vial walls exceeds aggregation) High-throughput screening where peptide cost per well is limiting 1mg/mL Standard in vitro assays, dose-response curves, cAMP functional a

This comparison does not assign a generated winner or score.

  • 0.5mg/mL
  • Receptor binding assays, low-density cell cultures
  • 21–28 days
  • Low (adsorption to vial walls exceeds aggregation)
  • High-throughput screening where peptide cost per well is limiting
  • 1mg/mL
  • Standard in vitro assays, dose-response curves, cAMP functional assays
  • 28–35 days
  • Very low
  • Default concentration for most melanocortin receptor research
  • 1.5mg/mL
  • High-density cell cultures, tissue penetration studies
  • Low-moderate
  • Applications requiring higher local peptide concentrations in media
  • 2mg/mL
  • Stability studies, accelerated degradation testing, formulation development
  • 14–21 days
  • Moderate (5–10% batch precipitation)
  • Maximum recommended for aqueous storage; used primarily for analytical validation
  • >2.5mg/mL
  • Not recommended
  • <14 days
  • High (15–25% visible aggregation)
  • Avoid unless using non-aqueous solvent systems with published protocols
More references

Related material